State Of Wyoming Amgen Inc Transaction History

State Of Wyoming

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $56,849 - $70,579	260 New	260 $69,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $3,612 - $4,403	-16 Reduced 1.58%	995 $240,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $66,647 - $84,683	291 Added 40.42%	1,011 $265,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $161,611 - $182,268	720 New	720 $162,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $94,360 - $105,006	-409 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $57,668 - $63,795	-263 Reduced 39.14%	409 $99,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $13,921 - $15,932	70 Added 11.63%	672 $151,000
Q3 2021 Feb 14, 2022	BUY	$212.27 - $248.7 $127,786 - $149,717	602 New	602 $128,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.